These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3979067

  • 1. Hemodynamic effects of vasodilators on pulmonary hypertension in decompensated chronic obstructive pulmonary disease.
    Cerdá E, Esteban A, de la Cal MA, Fernández A, García A.
    Crit Care Med; 1985 Apr; 13(4):221-3. PubMed ID: 3979067
    [Abstract] [Full Text] [Related]

  • 2. Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: a combined radionuclide-hemodynamic study.
    Brent BN, Berger HJ, Matthay RA, Mahler D, Pytlik L, Zaret BL.
    Am J Cardiol; 1983 Jun; 51(10):1682-9. PubMed ID: 6407295
    [Abstract] [Full Text] [Related]

  • 3. Relationship between oxygen uptake and oxygen transport in stable patients with chronic obstructive pulmonary disease. Physiologic effects of nitroprusside and hydralazine.
    Brent BN, Matthay RA, Mahler DA, Berger HJ, Zaret BL, Lister G.
    Am Rev Respir Dis; 1984 May; 129(5):682-6. PubMed ID: 6721268
    [Abstract] [Full Text] [Related]

  • 4. Vasodilator therapy in microembolic porcine pulmonary hypertension.
    McLean RF, Prielipp RC, Rosenthal MH, Pearl RG.
    Anesth Analg; 1990 Jul; 71(1):35-41. PubMed ID: 2114065
    [Abstract] [Full Text] [Related]

  • 5. The effects of hydralazine on exercise capacity in pulmonary hypertension secondary to chronic obstructive pulmonary disease.
    Dal Nogare AR, Rubin LJ.
    Am Rev Respir Dis; 1986 Mar; 133(3):385-9. PubMed ID: 3954247
    [Abstract] [Full Text] [Related]

  • 6. Differential hemodynamic and sympathoadrenal effects of sodium nitroprusside and hydralazine in hypertensive subjects.
    Shepherd AM, Irvine NA.
    J Cardiovasc Pharmacol; 1986 Mar; 8(3):527-33. PubMed ID: 2425168
    [Abstract] [Full Text] [Related]

  • 7. Detrimental effects of hydralazine in patients with chronic air-flow obstruction and pulmonary hypertension. A combined hemodynamic and radionuclide study.
    Tuxen DV, Powles AC, Mathur PN, Pugsley SO, Campbell EJ.
    Am Rev Respir Dis; 1984 Mar; 129(3):388-95. PubMed ID: 6322627
    [Abstract] [Full Text] [Related]

  • 8. A comparison of the acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension.
    Groves BM, Rubin LJ, Frosolono MF, Cato AE, Reeves JT.
    Am Heart J; 1985 Dec; 110(6):1200-4. PubMed ID: 3907315
    [Abstract] [Full Text] [Related]

  • 9. Effects of hydralazine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Keller CA, Shepard JW, Chun DS, Dolan GF, Vasquez P, Minh VD.
    Am Rev Respir Dis; 1984 Oct; 130(4):606-11. PubMed ID: 6486560
    [Abstract] [Full Text] [Related]

  • 10. Hemodynamic effects of nitroprusside and hydralazine in experimental cardiac tamponade.
    Fowler NO, Gabel M, Holmes JC.
    Circulation; 1978 Mar; 57(3):563-7. PubMed ID: 624165
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine.
    Adnot S, Defouilloy C, Brun-Buisson C, Abrouk F, Piquet J, Lemaire F.
    Am Rev Respir Dis; 1987 Feb; 135(2):288-93. PubMed ID: 3813189
    [Abstract] [Full Text] [Related]

  • 12. Comparison of nitroprusside and hydralazine in hypertensive pregnant ewes.
    Ring G, Krames E, Shnider SM, Wallis KL, Levinson G.
    Obstet Gynecol; 1977 Nov; 50(5):598-602. PubMed ID: 909667
    [Abstract] [Full Text] [Related]

  • 13. Effects of hydralazine on mouth occlusion pressure and ventilatory response to hypercapnia in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Corriveau ML, Shepard JW, Dolan GF.
    Am Rev Respir Dis; 1987 Jan; 135(1):118-22. PubMed ID: 3800141
    [Abstract] [Full Text] [Related]

  • 14. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.
    Franciosa JA, Pierpont G, Cohn JN.
    Ann Intern Med; 1977 Apr; 86(4):388-93. PubMed ID: 848799
    [Abstract] [Full Text] [Related]

  • 15. Hemodynamic effects of sodium nitroprusside in patients with ventricular septal defect.
    Subramanyam R, Tandon R, Shrivastava S.
    Eur J Pediatr; 1982 Jul; 138(4):307-10. PubMed ID: 7128637
    [Abstract] [Full Text] [Related]

  • 16. Hemodynamic effect of hydralazine in advanced, stable chronic obstructive pulmonary disease with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.
    Lupi-Herrera E, Seoane M, Verdejo J.
    Chest; 1984 Feb; 85(2):156-63. PubMed ID: 6692695
    [Abstract] [Full Text] [Related]

  • 17. Effects of indomethacin on pulmonary hemodynamics and gas exchange in patients with pulmonary artery hypertension, interference with hydralazine.
    Adnot S, Defouilloy C, Brun-Buisson C, Piquet J, de Cremoux H, Lemaire F.
    Am Rev Respir Dis; 1987 Dec; 136(6):1343-9. PubMed ID: 3688636
    [Abstract] [Full Text] [Related]

  • 18. Effects of vasodilators on pulmonary hemodynamics and gas exchange in left ventricular failure.
    Pierpont G, Hale KA, Franciosa JA, Cohn JN.
    Am Heart J; 1980 Feb; 99(2):208-16. PubMed ID: 7352403
    [No Abstract] [Full Text] [Related]

  • 19. Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure.
    Franciosa JA, Cohn JN.
    Am J Med; 1978 Jul; 65(1):126-33. PubMed ID: 685986
    [Abstract] [Full Text] [Related]

  • 20. Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease.
    Packer M, Medina N, Yushak M.
    J Am Coll Cardiol; 1984 Nov; 4(5):890-901. PubMed ID: 6491082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.